The amount of money spent on staff isn't good for the return. The value of addressable markets seems preposterously low except for the hormonal mist. The newly released nitroglyycerin ointment is a very niche market but I think it would sell in huge amounts in San Francisco provided it isn't stolen off the shelves first. The cost of doing business here is a killer for their balance sheet which is certainly not balanced. The next 3 months will tell whether it hands like a gang plank on an old merchant vessel or it becomes a see saw ride on the ASX. All i can say is good luck.
ACR Price at posting:
2.3¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)